Blood samples may reveal how to stop transplant complications
NCT ID NCT07150468
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study involved 146 patients with blood cancers who received a stem cell transplant from a donor. Researchers collected blood and tissue samples over a year to study immune cells linked to graft-versus-host disease (GVHD), a common complication where donor cells attack the patient's body. The goal was to understand the immune mechanisms behind GVHD to help develop future prevention strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward better ways to prevent graft-versus-host disease in stem cell transplant patients.
- What could go wrong
- This is an observational study that only collected blood and tissue samples; it does not test any new treatment. The findings may not lead directly to a prevention strategy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells stop blood cancer relapse?
- Could muscle loss predict blood cancer outcomes?
- Can a modified enzyme starve Hard-to-Treat blood cancers?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can donor immune cells tame stem cell transplant risks?
- Could a platelet-boosting drug shorten recovery after stem cell transplants?